Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2023	$ 10	$ 86,496,076	$ (93,365,515)	$ (6,869,429)
Balance, shares at Dec. 31, 2023	97,293
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees	$ 2	3,115,282		3,115,284
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares	23,650
Issuance of common stock in public offering, net of fees	$ 30	6,432,862		6,432,892
Issuance of common stock in public offering, net of fees, shares	296,000
Issuance of pre-funded warrants in connection with the conversion of related party note payable		2,734,739		2,734,739
Capital contribution in connection with conversion of related party note payable		586,511		586,511
Issuance of restricted common stock		24,024		24,024
Issuance of restricted common stock, shares	596
Stock-based compensation expense		164,575		164,575
Net loss			(2,972,477)	(2,972,477)
Balance at Mar. 31, 2024	$ 42	99,554,069	(96,337,992)	3,216,119
Balance, shares at Mar. 31, 2024	417,539
Balance at Dec. 31, 2023	$ 10	86,496,076	(93,365,515)	(6,869,429)
Balance, shares at Dec. 31, 2023	97,293
Net loss				(10,328,505)
Balance at Sep. 30, 2024	$ 305	115,731,278	(103,694,020)	12,037,563
Balance, shares at Sep. 30, 2024	3,044,165
Balance at Mar. 31, 2024	$ 42	99,554,069	(96,337,992)	3,216,119
Balance, shares at Mar. 31, 2024	417,539
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees	$ 12	1,109,990		1,110,002
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares	121,279
Issuance of restricted common stock	$ 1	98,433		98,434
Issuance of restricted common stock, shares	11,652
Stock-based compensation expense		254,331		254,331
Net loss			(3,230,385)	(3,230,385)
Issuance of common stock upon exercise of pre-funded warrants	$ 9	(9)
Issuance of common stock upon exercise of pre-funded warrants, shares	86,334
Change in fair value of derivative		20,708		20,708
Warrant inducement	$ 14	1,614,549		1,614,563
Warrant inducement, shares	143,958
Balance at Jun. 30, 2024	$ 78	102,652,071	(99,568,377)	3,083,772
Balance, shares at Jun. 30, 2024	780,762
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees	$ 212	11,791,412		11,791,624
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares	2,116,303
Stock-based compensation expense		393,771		393,771
Net loss			(4,125,643)	(4,125,643)
Issuance of common stock upon exercise of pre-funded warrants	$ 2	(2)
Issuance of common stock upon exercise of pre-funded warrants, shares	16,498
Change in fair value of derivative		894,039		894,039
Share adjustment due to fractional rounding of August 2024 reverse split	$ 13	(13)
Share adjustment due to fractional rounding of August 2024 reverse split, shares	130,602
Balance at Sep. 30, 2024	$ 305	115,731,278	(103,694,020)	12,037,563
Balance, shares at Sep. 30, 2024	3,044,165
Balance at Dec. 31, 2024	$ 340	117,380,285	(109,925,120)	7,455,505
Balance, shares at Dec. 31, 2024	3,402,306
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees	$ 42	1,920,315		1,920,357
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares	423,893
Stock-based compensation expense		357,649		357,649
Net loss			(3,852,678)	(3,852,678)
Change in fair value of derivative		49,987		49,987
Balance at Mar. 31, 2025	$ 382	119,708,236	(113,777,798)	5,930,820
Balance, shares at Mar. 31, 2025	3,826,199
Balance at Dec. 31, 2024	$ 340	117,380,285	(109,925,120)	7,455,505
Balance, shares at Dec. 31, 2024	3,402,306
Net loss				(16,177,001)
Balance at Sep. 30, 2025	$ 596	129,575,211	(126,102,121)	3,473,686
Balance, shares at Sep. 30, 2025	5,977,358
Balance at Mar. 31, 2025	$ 382	119,708,236	(113,777,798)	5,930,820
Balance, shares at Mar. 31, 2025	3,826,199
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees	$ 104	4,182,295		4,182,399
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares	1,038,969
Issuance of restricted common stock	$ 2	96,667		96,669
Issuance of restricted common stock, shares	24,122
Stock-based compensation expense		90,721		90,721
Net loss			(4,983,261)	(4,983,261)
Change in fair value of derivative		194,526		194,526
Balance at Jun. 30, 2025	$ 488	124,272,445	(118,761,059)	5,511,874
Balance, shares at Jun. 30, 2025	4,889,290
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees	$ 37	1,462,844		1,462,881
Issuance of common stock in connection with At the Market Offering and Purchase Agreement, net of fees, shares	373,157
Issuance of restricted common stock
Stock-based compensation expense		592,824		592,824
Net loss			(7,341,062)	(7,341,062)
Issuance cost and change in fair value of derivative	$ 12	772,157		772,169
Commitment shares and discount on Purchase Agreement, shares	120,424
Issuance of common stock in connection with Promissory Note exchange agreements	$ 59	2,474,941		2,475,000
Issuance of common stock in connection with Promissory Note exchange agreements, shares	594,487
Balance at Sep. 30, 2025	$ 596	$ 129,575,211	$ (126,102,121)	$ 3,473,686
Balance, shares at Sep. 30, 2025	5,977,358

Cingulate Inc. 10-Q